Literature DB >> 9426016

Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents.

R Hoffmann1, G S Mintz, R Mehran, A D Pichard, K M Kent, L F Satler, J J Popma, H Wu, M B Leon.   

Abstract

OBJECTIVES: This study sought to evaluate the clinical, procedural, preinterventional and postinterventional quantitative coronary angiographic (QCA) and intravascular ultrasound (IVUS) predictors of restenosis after Palmaz-Schatz stent placement.
BACKGROUND: Although Palmaz-Schatz stent placement reduces restenosis compared with balloon angioplasty, in-stent restenosis remains a major clinical problem.
METHODS: QCA and IVUS studies were performed before and after intervention (after stent placement and high pressure adjunct balloon angioplasty) in 382 lesions in 291 patients treated with 476 Palmaz-Schatz stents for whom follow-up QCA data were available 5.5 +/- 4.8 months (mean +/- SD) later. Univariate and multivariate predictors of QCA restenosis (> or = 50% diameter stenosis at follow-up, follow-up percent diameter stenosis [DS] and follow-up minimal lumen diameter [MLD]) were determined.
RESULTS: Three variables were the most consistent predictors of the follow-up angiographic findings: ostial lesion location, IVUS preinterventional lesion site plaque burden (plaque/total arterial area) and IVUS assessment of final lumen dimensions (whether final lumen area or final MLD). All three variables predicted both the primary (binary restenosis) and secondary (follow-up MLD and follow-up DS) end points. In addition, a number of variables predicted one or more but not all the end points: 1) restenosis (IVUS preinterventional lumen and arterial area); 2) follow-up DS (QCA lesion length); and 3) follow-up MLD (QCA lesion length and preinterventional MLD and DS and IVUS preinterventional lumen and arterial area).
CONCLUSIONS: Ostial lesion location and IVUS preinterventional plaque burden and postinterventional lumen dimensions were the most consistent predictors of angiographic in-stent restenosis.

Entities:  

Mesh:

Year:  1998        PMID: 9426016     DOI: 10.1016/s0735-1097(97)00438-5

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Mechanical properties and imaging characteristics of remanufactured intravascular ultrasound catheters.

Authors:  R Hoffmann; P Haager; G Mintz; H Klues
Journal:  Int J Card Imaging       Date:  2000-02

2.  Long-term angiographic outcomes of post-sirolimus-eluting stent restenosis in Japanese patients.

Authors:  Nobuyuki Miyai; Noriyuki Kinoshita; Keisuke Oota; Takeshi Yamada; Reo Nakamura; Hidekazu Irie; Tetsuo Hashimoto; Shyunichi Tamaki; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

3.  Drug eluting stents: maximising benefit and minimising cost.

Authors:  J Gunn; A C Morton; C Wales; C M H Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

4.  Incidence of stent under-deployment as a cause of in-stent restenosis in long stents.

Authors:  Olivier F Bertrand; Robert De Larochellière; Michel Joyal; Raoul Bonan; Rosaire Mongrain; Jean-Claude Tardif
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

Review 5.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

6.  Impact of post-dilatation with a focal expanding balloon for optimization of intracoronary stenting.

Authors:  Fumiaki Mori; Yukio Tsurumi; Nobuhisa Hagiwara; Hiroshi Kasanuki
Journal:  Heart Vessels       Date:  2007-05-21       Impact factor: 2.037

7.  Effectiveness of new generation drug-eluting stents in ostial right coronary artery lesions.

Authors:  Matteo De Rosa; Gaetano Santulli
Journal:  Int J Cardiol       Date:  2018-01-28       Impact factor: 4.164

8.  Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation.

Authors:  Hideshi Ishii; Toru Kataoka; Yoshiki Kobayashi; Takara Tsumori; Hiroaki Takeshita; Ryo Matsumoto; Nobuyuki Shirai; Hiroki Nishioka; Takao Hasegawa; Shinji Nakata; Yoshihisa Shimada; Shoichi Ehara; Takashi Muro; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2011-01-08       Impact factor: 2.037

9.  Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction.

Authors:  Alexandre A Cochet; Luc Lorgis; Alain Lalande; Marianne Zeller; Jean-Claude Beer; Paul M Walker; Claude Touzery; Jean-Eric Wolf; François Brunotte; Yves Cottin
Journal:  Eur Radiol       Date:  2009-04-07       Impact factor: 5.315

10.  Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm.

Authors:  Sang-Hoon Seol; Doo-Il Kim; Yang-Chun Han; Ki-Hun Kim; Dong-Kie Kim; Young-Bok Kim; Ung Kim; Tae-Hyun Yang; Dae-Kyeong Kim; Dong-Soo Kim
Journal:  Korean Circ J       Date:  2009-10-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.